HCA Holdings, Inc. (NYSE:HCA) updated its FY17 earnings guidance on Tuesday. The company provided EPS guidance of $6.45-6.70 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.55. The company issued revenue guidance of $43.0-44.0 billion, compared to the consensus revenue estimate of $43.16 billion.
A number of research firms have issued reports on HCA. BidaskClub lowered shares of HCA Holdings from a hold rating to a sell rating in a report on Monday, July 24th. Zacks Investment Research lowered shares of HCA Holdings from a hold rating to a sell rating in a report on Thursday, July 27th. Piper Jaffray Companies reiterated a buy rating and set a $82.00 target price on shares of HCA Holdings in a report on Wednesday. Mizuho reduced their price objective on shares of HCA Holdings from $85.00 to $84.00 and set a buy rating on the stock in a report on Wednesday. Finally, Jefferies Group LLC reduced their price objective on shares of HCA Holdings from $90.00 to $88.00 and set a buy rating on the stock in a report on Wednesday. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and sixteen have issued a buy rating to the company. The stock presently has an average rating of Buy and an average target price of $90.00.
HCA Holdings (NYSE:HCA) last announced its earnings results on Tuesday, October 31st. The company reported $1.21 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $1.21. The firm had revenue of $10.70 billion during the quarter, compared to analyst estimates of $10.70 billion. HCA Holdings had a net margin of 6.13% and a negative return on equity of 47.16%. HCA Holdings’s revenue was up 4.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.45 EPS.
HCA Holdings declared that its Board of Directors has initiated a share buyback plan on Tuesday, October 31st that authorizes the company to repurchase $2.00 billion in shares. This repurchase authorization authorizes the company to reacquire shares of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s leadership believes its stock is undervalued.
In related news, insider Michael S. Cuffe sold 2,150 shares of the stock in a transaction dated Tuesday, October 17th. The shares were sold at an average price of $78.00, for a total value of $167,700.00. Following the completion of the transaction, the insider now owns 12,476 shares in the company, valued at approximately $973,128. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders sold a total of 6,450 shares of company stock valued at $511,163 in the last quarter. 2.90% of the stock is currently owned by insiders.
HCA Holdings Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
What are top analysts saying about HCA Holdings Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for HCA Holdings Inc. and related companies.